Hypoglycemic and pancreatic protective effects of Portulaca oleracea extract in alloxan induced diabetic rats

BMC Complementary and Alternative Medicine

Volumn 17, Issue 1, 2017, Pages

  Ramadan, Basma K ^a   Schaalan, Mona F ^b   Tolba, Amina M ^a  

^a AL AZHAR UNIVERSITY   (Egypt)

^b MISR INTERNATIONAL UNIVERSITY   (Egypt)

Author keywords

B cell mass; Diabetes; IL 6; Portulaca oleracea; TNF

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 6; PORTULACA OLERACEA EXTRACT; TUMOR NECROSIS FACTOR; ALLOXAN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; PLANT EXTRACT; PROTECTIVE AGENT;

ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; RAT; SIGNAL TRANSDUCTION; TREATMENT DURATION; WISTAR RAT; ANIMAL; BLOOD; CHEMICALLY INDUCED; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; HUMAN; LIVER; METABOLISM; PANCREAS; PHYTOTHERAPY; PORTULACA;

ALLOXAN; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTERLEUKIN-6; LIVER; MALE; PANCREAS; PHYTOTHERAPY; PLANT EXTRACTS; PORTULACA; PROTECTIVE AGENTS; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85009231854     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-016-1530-1     Document Type: Article

References (57)

1. Ketan H, Annapurna A. The effect of quercetin on blood glucose levels of normal and streptozotocin induced diabetic (type i & type ii) rats. IJPCBS. 2014;4(3):613-9.
2. Piya MK, Tahrani AA, Barnett AH. Emerging treatment options for type 2 diabetes. J Clin Diabetes Br Pharmacol. 2010;70:631-44.
3. Si YL, Zhao YL, Hao HJ. MSCs: biological characteristics, clinical applications and their outstanding concerns. Ageing Res Rev. 2011;10:93-103.
4. Waltner-Law M, Wang X, Law B. Epigallo-catechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem. 2002;277:34933-40.
5. Arise RO, Malomo SO, Adebayo JO, Igunnu A. Effects of aqueous extract of Eucalyptus globules on lipid peroxidation and selected enzymes of rat liver. J Med Plant Res. 2009;3(2):077-81.
6. Ogbourne SM, Parsons PG. The value of nature's natural product library for the discovery of New Chemical Entities: the discovery of ingenol mebutate. Fitoterapia. 2014;98:36-44.
7. El-Abhar HS, Schaalan MF. Phytotherapy in diabetes: review on potential mechanistic perspectives. World J Diabetes. 2014;5(2):176-97.
8. Zhou YX, Xin HL, Rahman K, Wang SJ, Peng C, Zhang H. Portulaca oleracea L.: a review of phytochemistry and pharmacological effects. Biomed Res Int. 2015;2015:925631.
9. Barbosa-Filho JM, Alencar AA, Nunes XP, Tomaz AC, Sena Filho JG, Athayde Filho PF. Sources of alpha, beta, gamma, delta and epsilon-carotenes: a twentieth century review. Rev Bras Farmacogn. 2008;18:135-54.
10. Sultana A, Rahman K. Portulaca oleracea Linn. A global Panacea with ethno-medicinal and pharmacological potential. Int J Pharm Pharm Sci. 2003;5(Suppl2):33-9.
11. Rahdari P, Hosseini SM, Tavakoli S. The studying effect of drought stress on germination, proline, sugar, lipid, protein and chlorophyll content in purslane (Portulaca oleracea L.) leaves. J Med Plants Res. 2012;6:1539-47.
12. Simopoulos AP. Omega-3 fatty acids and antioxidants in edible wild plants. Biol Res. 2004;37:263-78.
13. Uddin MK, Juraimi AS, Hossain MS, Nahar MA, Ali ME, Rahman MM. Purslane weed (Portulaca oleracea): a prospective plant source of nutrition, omega-3 fatty acid, and antioxidant attributes. Sci World J. 2014;2014:951019.
14. Hussein AM. Purslane extract effects on obesity-induced diabetic rats Fed a high-fat diet. Mal J Nut. 2010;16(3):419-29.
15. Lee AS, Lee YJ, Lee SM, Yoon JJ, Kim JS, Kang DG, Lee HS. Portulaca oleracea ameliorates diabetic vascular inflammation and endothelial dysfunction in db/db mice. Evid Based Complement Alternat Med. 2012;2012:741824.
16. Lee AS, Lee YJ, Lee SM, Yoon JJ, Kim JS, Kang DG, Lee HS. An aqueous extract of Portulaca oleracea ameliorates diabetic nephropathy through suppression of renal fibrosis and inflammation in diabetic db/db mice. Am J Chin Med. 2012;40(3):495-510.
17. Gong F, Li F, Zhang L, Li J, Zhang Z, Wang G. Hypoglycemic effects of crude polysaccharide from Purslane. Int J Mol Sci. 2009;10:880-8.
18. Bai Y, Zang X, Ma J, Xu G. Anti-diabetic effect of portulaca oleracea L. Polysaccharideandits mechanism in diabetic rats. Int J Mol Sci. 2016;25:17(8).
19. El-Sayed MIK. Effects of Portulaca oleracea L. seeds in treatment of type-2 diabetes mellitus patients as adjunctive and alternative therapy. J. Ethnopharmacol. 2011;137:643-51.
20. Gu JF, Zheng ZY, Yuan JR, Zhao BJ, Wang CF, Zhang L, Xu QY, Yin GW, Feng L, Jia XB. Comparison on hypoglycemic and antioxidant activities of the fresh and dried Portulaca oleracea L. in insulin-resistant HepG2 cells and streptozotocin-induced C57BL/6 J diabetic mice. J Ethnopharmacol. 2015;161:214-23.
21. Suresh Y, Das UN. Available protective action of arachidonic acid against alloxan- induced cytotoxicity and diabetes mellitus. Harcourt Publishers. 2001;64(1):37-52.
22. Anusha M, Venkateswarlu V, Prabhakaran S, Shareen Taj B, Kumari PD. Hepatoprotective activity of aqueous extract of Portulaca oleracea combination with lycopene in rats. Indian J Pharmacol. 2011;43(5):563-7.
23. Danial JA, George SM. Peach dormancy in relation to indigenous inhibit applied growth substances. J Am Soc Sci. 1979;27:651-4.
24. Zhisen J, Mengcheng T, Jianming W. The determination of flavonoid contents in mulberry and their scavenging effect on super oxide radicals. Food Chem. 1999;64:555-9.
25. Goupy P, Hugues MP, Amiot M. Antioxidant composition and activity of barley (Hordeum vulgare) and malt extracts and of isolated phenolic compounds. J Sci Food Agric. 1999;79:1625-34.
26. Merken HM, Beecher GR. Measurement of food flavonoids by high-performance liquid chromatography: a review. J Agric Food Chem. 2000;48(3):577-99.
27. Wettestein DV. Chlorophyll -letate and der submikroskopischer from wockee Der plastischen. Exp Cell Res. 1957;2:427.
28. Rohilla A, Ali S. Alloxan induced diabetes: mechanisms and effects. Int J Res Pharma Biomedical Sci. 2012;3(2):819-21.
29. Federiuk I, Casey H, Quinn M, Wood M, Ward K. Induction of type-1 diabetes mellitus in laboratory rats by use of alloxan: route of administration, pitfalls, and insulin treatment. Comp Med. 2004;54:252-7.
30. Fernandes A, Guarino M. Understanding the in vivo relevance of S-nitrosothiols in insulin action. Clin Chim Acta. 2012;85:323-33.
31. Eastham RD. The low dose aspirin controversy solved at last. Br Med J (Clin Res Ed). 1985;29(6497):738.
32. Couri B, Vottarelli JC. Potential role of stem cell therapy in type 1 diabetes mellitus. Arq Bras Endocrinol Metabol. 2008;52(2):407-15.
33. Etuk E, Muhammed B. Evidence-based analysis of chemical method of induction of diabetes mellitus in experimental animals. Asian J Exp Biol. 2010;1:331-6.
34. Adeyi A, Idowu B, Mafiana C, Oluwalana S, Ajayi O, Akinloye O. Rat model of food-induced non-obese-type 2 diabetes mellitus: comparative pathophysiology and histopathol-ogy. Intl J Physiol Pathophysiol Pharmacol. 2012;1:51-8.
35. Adeyemi DO, Komolafa OA, Adewole OS, Obuotor EM, Abiodun AA, Adenowo TK. Histomorphological and morphometric studies of the pancreatic islet cells of diabetic rats treated with extract of Annonamuricata. Folia Morphol. 2010;69(2):92-100.
36. Naciye E. Antioxidant activity and phenolic compounds of fraction from Portulaca oleracea L. Food Chem. 2012;133(3):775-81.
37. Abd El-Aziz HA, Sobhy MH, Ahmed KA, Azza K, Abd El Hameed AK, Rahman ZA, Hassan WA. Chemical and remedial effects of purslane (portulaca oleracea) plant. Life Sci J. 2014;11(6):31-42.
38. Elkhayat ES, Ibrahim SR, Aziz MA. Portulene, a new diterpene from Portulaca oleracea L. J Asian Nat Prod Res. 2008;10(11-12):1039-43.
39. Shen L, Lu F. Effects of Portulaca oleracea on insulin resistance in rats with Type 2 diabetes mellitus. Chin J Integr Med. 2003;9:289-92.
40. Akinlade A, Ogbera A, Fasanmade O, Olamoyegun O. Serum C-peptide assay of patients with hyperglycemic emergencies at the Lagos State University Teaching Hospital (LASUTH), Ikeja. Intl Arch Med. 2014;7:50.
41. Gabr M, Zakaria M, Refaie A, Khater S, Ashamallah S, Ismail A, El-Halawani S, Ghoneim M. Differentiation of human bone marrow-derived mesenchymal stem cells into insulin-producing cells: evidence for further maturation in vivo. Bio-Med Res Intl. 2015;2015:575837:1-10.
42. Kameswararao B, Kesavulu MM, Apparao C. Evaluation of antidiabetic effect of Momordica cymbalaria fruit in alloxan-diabetic rats. Fitoterapia. 2003;74:7-13.
43. Arivarasan A, Rana G, Sharma A, Kumar M, Jhang K, Chakraborty A. Clinical management of lipid profile, renal & liver function versus Hb A1c profile in diabetes affected patients of vellore, Tamil Nadu, India. Afr J Pharma. 2012;6(40):2832-6.
44. Shbaklo H, Azar S, Terwedow H, Halaby G, Naja R, Zalloua P. No association between the 1031 polymorphism in the TNFα promoter region and Type I diabetes. Hum Immunol. 2003;64:633-8.
45. Alexandrak K, Ziakas P, Kalfoutis A. Cytokine secretion in long standing diabetes mellitus types 1 and 2: association of low grade systemic inflammation. J Clin Immunuol. 2008;26:1824-9.
46. Pennathur S, Heinecke J. Mechanisms for oxidative stress in diabetic cardiovascular disease. Anti-oxidant Redox Signal. 2007;9:955-69.
47. Mirza S, Hossain M, Mathews C, Martinez P, Pino P, Gay J, Rentfro A, McCormick J, Fisher-Hoch S. Type 2-diabetes is associated with elevated levels of TNFα, IL-6, and adipo-nectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study. J Cytol. 2012;57:136-42.
48. Sridevi D, Venugopal SK, Singh U, Jialal I. Hyperglycemia induces monocytic release of interleukin-6 via induction of proteinkinase C, α and B. Diabetes. 2005;54:85-91.
49. Lee A, Kim J, Lee Y, Kang D, Lee H. Anti-TNFα activity of Portulaca oleracea in vascular endothelial cells. Intl J Mol Sci. 2012;13:5628-44.
50. Xiao F, Lu F, Xu L. Effect of different parts of Portulaca on the levels of TNFα and IL-6 in the supernatant of cultured adipose cell. Zhongguo Zhong Yao Za Zhi. 2015;30:1763-6.
51. Oshaghi EA, Khodadadi I, Tavilani H, Goodarzi MT. Aqueous extract of Anethum Graveolens L. has potential antioxidant and antiglycation effects. Iran J Med Sci. 2016;41(4):328-33.
52. Bhatia A, Khera N. Hypoglycaemic activity of orally administered woodfordia fruticosa flower extract in alloxan-induced diabetic mice. Int J Life Sci Biolechnol Pharm Res. 2013;2:2250-3137.
53. Hassan N, Emam M. Protective effect of camel milk and ginkgo biloba extract against alloxan-induced diabetes in rats. J Diabetes Metab. 2012;3:231-6.
54. Ojo R, Memudu A, Akintayo C, Akpan I. Preventive effect of allium sativumon alloxan-induced diabetic rat. J Agric Biol Sci. 2012;8:609-12.
55. Esmaillzadeh A, Zakizadeh E, Faghihimani E, Gohari M, Jazayeri S. The effect of purslane seeds on glycemic status and lipid profiles of persons with type 2 diabetes: a randomized controlled cross-over clinical trial. J Res Med Sci. 2015;20(1):47-53.
56. Bai Y, Zang X, Ma J, Xu G. Anti-diabetic effect of Portulaca oleracea L. Polysaccharideandits mechanism in diabetic rats. Int J Mol Sci. 2016;17:1201-15.
57. Guyton A, Hall J. Dietary balance; regulation of feeding; obesity and starvation; vitamins, and minerals. In: Textbook of medical physiology. 12th ed. Philadelphia: W.B. Saunders; 2011. p. 843-57.